Bajaj Healthcare Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.

Results View source PDF Explain this filing

BAJAJHCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹533.35

prior close

₹535.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.5%-4.0% vs market

Pharmaceuticals peers, median of 149sector+0.8%-3.3% vs sector

On the reaction day the stock moved 4.0 pts less than Nifty Microcap 250 and 3.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-5.3

10m

-5.6

15m

-7.2

30m

-6.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5+1.5-4.0+0.8-3.3

Next day

-6.6+1.8-8.5+0.9-7.6

-9.1+1.1-10.2+0.0-9.1

-12.4-0.5-11.9-2.1-10.3

-11.0+0.0-11.0-1.4-9.6

-12.1-0.3-11.8-2.0-10.1

-14.6-1.7-12.9-3.3-11.3

15d

-16.2+0.1-16.3-3.1-13.1

-20.9-2.9-18.1-5.2-15.7

-8.1-3.0-5.2-5.7-2.4

-13.6+1.0-14.6-5.1-8.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Bajaj Healthcare Limited has submitted its financial results for the quarter ended June 30, 2025 to NSE, as required under listing regulations. The filing covers the unaudited Q1 FY2026 earnings. Specific revenue, profit, margin figures and auditor observations are not disclosed in the announcement and would be available in the detailed results document filed with the exchange.

Likely market impact

Investors should review the detailed financial results document to assess the company's quarterly performance, including revenue growth, profitability, and margin trends. The submission itself is a routine compliance filing and does not indicate any specific positive or negative event.